Description:
Z1041: Early Termination of Follow-up (ETFU) Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=211E6516-FD7F-6E79-E044-0003BA3F9857
Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=211E6516-FD7F-6E79-E044-0003BA3F9857
Keywords:
Versions (2) ▾
- 8/26/12
- 1/9/15
Uploaded on:
January 9, 2015
DOI:
No DOI assigned. To request one please log in.License:
Creative Commons BY-NC 3.0 LegacyModel comments:
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for:
Item comments for:
In order to download data models you must be logged in. Please log in or register for free.
Breast Cancer NCT00513292 Follow-Up - Z1041: Early Termination of Follow-up (ETFU) - 2533765v1.0
- StudyEvent: Z1041: Early Termination of Follow-up (ETFU)